Showing 2431-2440 of 7240 results for "".
Risks of Multiple Primary Melanomas
https://practicaldermatology.com/topics/practice-management/risks-of-multiple-primary-melanomas/21058/Studies offer clarity on risks and patterns after diagnosis, as well as survival outcomes.Currents: Use as Directed
https://practicaldermatology.com/topics/psoriasis/currents-use-as-directed/21082/Strategies to improve outcomes and enhance adherence in psoriasis, acne, eczema, and aestheticsIncreasing Profitability by Delivering a Better Patient Payment Experience
https://practicaldermatology.com/topics/practice-management/increasing-profitability-by-delivering-a-better-patient-payment-experience/21081/Politicizing Certification
https://practicaldermatology.com/topics/practice-management/politicizing-certification/21092/Employee Engagement
https://practicaldermatology.com/topics/practice-management/employee-engagement/21267/Promoting employee engagement is key to success in the workplace.Beware of International Injectables
https://practicaldermatology.com/topics/practice-management/beware-of-international-injectables/19053/Julie Woodward, MD. Associate Professor of Ophthalmology Associate Professor in Dermatology; Chief, Oculoplastic and Reconstructive Surgery Service, Duke University Medical Center, addresses the challenges that arise when patients receive unknown injectables overseas. Complications from improperly uDermatology and the ICD-10 Code Conundrum
https://practicaldermatology.com/topics/practice-management/dermatology-and-the-icd-10-code-conundrum/21372/EHRs equipped for ICD-10 can make the impending transition smooth for any practice.Allergan Commemorates 25th Anniversary of the First Two Approved Uses of BOTOX® (onabotulinumtoxinA)
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/allergan-commemorates-25th-anniversary-of-the-first-two-approved-uses-of-botox-onabotulinumtoxina-/19136/Allergan, Inc. (NYSE: AGN) today announced the launch of a video recognizing the physician pioneers and patient communities who contributed to the development of BOTOX® (onabotulinumtoxinA), one of the most recognized pharmaceutical brands in the United States. The video kicks off a year-long campaiDermatologic Devices: The State of the Art
https://practicaldermatology.com/topics/general-topics/dermatologic-devices-the-state-of-the-art/21409/Innovations continue in the realm of device-based procedures, leaving physicians with many options to incorporate devices into practice.Prescribing Pitfalls Part II: Techniques for Prescribing Success
https://practicaldermatology.com/topics/practice-management/prescribing-pitfalls-part-ii-techniques-for-prescribing-success/21413/Simple strategies employed in the office can improve the likelihood of treatment success and enhance patient satisfaction.